TD-214

N/A

Report date: 2023/09/08 17:40:32
NME

Base Information

Drug NameTD-214
Drug Alias NameProbenecid related analog (TrippBio)PanCytoVir™ related analog (TrippBio)TD-214
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUric acid transporter 1 inhibitorsCytochrome P450 2C9 inhibitorsOrganic Anion Transporter 3 inhibitors +[4] 
TargetsUric acid transporter 1Cytochrome P450 2C9Organic Anion Transporter 3 +[4] 
Therapy Area/IndicationsRespiratory Syncytial Virus InfectionsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Georgia
China Registration ClassN/A

Develop Information

Active CompaniesTrippBio Inc
Inactive CompaniesN/A
Active IndicationsRespiratory Syncytial Virus InfectionsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A